Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

BiBBInstruments

2,60 SEK

0,00 %

Mindre end 1K følgere

BIBB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
0,00 %
-22,16 %
-32,47 %
-12,46 %
-15,31 %
-21,89 %
-52,59 %
-62,95 %
-63,69 %

BiBBInstruments operates in the medical technology sector. The company develops biopsy instruments based on its own technology platform. The technology is mainly used in specialist healthcare and surgical departments in the treatment of various forms of cancer. The products are sold as disposable instruments with a developed drilling function and are used at the diagnostic stage. The company was founded in 2013 and is headquartered in Lund.

Læs mere
Markedsværdi
105,92 mio. SEK
Aktieomsætning
48,74 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning t

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
10.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelsefor 15 timer siden

BioStock: BiBBInstruments validates clinical need during US tour

BiBBInstruments
Pressemeddelelsei går

BibbInstruments AB: U.S. Tour Fall 2025 - BiBB Strengthens Its Presence in the American Market

BiBBInstruments
Pressemeddelelse10.11.2025, 06.48

BioStock: BiBBInstruments off the starting blocks for its U.S. launch

BiBBInstruments

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse9.9.2025, 07.45

BibbInstruments AB: Initial Results from Mayo Clinic Indicate Potential of EndoDrill GI in Tissue Culture-Based Pancreatic Cancer Research

BiBBInstruments
Pressemeddelelse4.9.2025, 06.56

BibbInstruments AB: BiBB Engages EUS Pioneer Professor Peter Vilmann as Scientific Advisor

BiBBInstruments
Pressemeddelelse25.8.2025, 05.26

BioStock: BioStock: BiBBInstruments’ CEO looks forward to the upcoming launch

BiBBInstruments
Pressemeddelelse13.8.2025, 08.52

BioStock: BiBBInstruments’ CEO comments on the results of a clinical case series for EndoDrill GI in the U.S.

BiBBInstruments
Selskabsmeddelelse11.8.2025, 07.27

BibbInstruments AB: Henry Ford St. John Hospital Reports First U.S. Liver Biopsy Cases with EndoDrill GI

BiBBInstruments
Selskabsmeddelelse24.6.2025, 07.41

BibbInstruments AB: Decision to Grant Third EndoDrill[®] Patent in Japan

BiBBInstruments
Pressemeddelelse23.6.2025, 07.45

BioStock: BioStock: BiBBInstruments secures exclusive distribution agreement in the U.S.

BiBBInstruments
Selskabsmeddelelse18.6.2025, 12.04

BibbInstruments AB: BiBBInstruments announces date for conversion of exercised warrants of series TO 1 into shares

BiBBInstruments
Selskabsmeddelelse12.6.2025, 07.57

BibbInstruments AB: BiBB signs exclusive distribution agreement with TaeWoong Medical USA

BiBBInstruments
Selskabsmeddelelse9.6.2025, 13.22

BibbInstruments AB: BiBBInstruments AB announces outcome of subscription period for warrants of series TO 1

BiBBInstruments
Pressemeddelelse30.5.2025, 07.00

BibbInstruments AB: BiBBInstruments AB - Receives intention of subscription regarding warrants of series TO 1 from management and board members

BiBBInstruments
Pressemeddelelse22.5.2025, 06.55

BibbInstruments AB: BiBBInstruments AB: Publishes a letter from CEO Fredrik Lindblad

BiBBInstruments
Selskabsmeddelelse22.5.2025, 06.30

BibbInstruments AB: BiBBInstruments AB - The subscription period for warrants of series TO 1 begins today

BiBBInstruments
Selskabsmeddelelse19.5.2025, 08.57

BibbInstruments AB: BiBBInstruments AB: The subscription price for warrants of series TO 1 set at SEK 3.25 per share

BiBBInstruments
Selskabsmeddelelse15.5.2025, 10.30

BibbInstruments AB: BiBB Receives U.S. Patent Notice of Allowance for EndoDrill[®]

BiBBInstruments
Selskabsmeddelelse2.5.2025, 16.01

BibbInstruments AB: BiBB and TaeWoong Medical USA Sign Letter of Intent for U.S. Commercialization of EndoDrill[ ]GI

BiBBInstruments
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.